BioCentriq and panCELLa execute research agreement to study stem cell-derived Natural Killer cell expansion technology

Agreement evaluates induced pluripotent stem cell-derived feeder cells to improve NK manufacturing NEWARK, N.J. and SEATTLE, May 2, 2023 /PRNewswire/ -- BioCentriq, Inc. and panCELLa, a Pluristyx Company, announced that they have signed a research agreement designed to evaluate the...